An Israeli study has identified TRIM63 as a significant genetic contributor to hypertrophic cardiomyopathy (HCM)—the most ...

In the heart of Austin, where music and innovation often intersect, beloved local artist Casey McPherson's story has struck a ...

Although lifestyle choices can lead to heart disease, there are certain diagnoses that are the product of genetics alone.

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

It has been recognised as a risk factor for heart disease since 1974, but its hereditary nature has made it particularly challenging to address. Unlike other cardiovascular risk factors influenced by ...

Lilly's drug is one of several being tested to treat high Lp(a), a risk factor for heart disease that affects an estimated 1.4 billion people worldwide, including 64 million people in the U.S.

Objective: This study evaluated the utility of single nucleotide polymorphism (SNP) microarray analysis in prenatal genetic assessment of fetuses diagnosed with congenital heart disease (CHD), ...

Genetic disorders are prevalent in patients with congenital heart disease (CHD), but genetic evaluations are underutilized and nonstandardized. We sought to quantify a dysmorphology score and develop ...

While less well recognized than population-focused EAPs, the concept of a personalized EAP (pEAP) is emerging for athletes who are working toward returning to play and have a known SCA risk−carrying ...

Inherited or genetic heart disorders ... Elevated Lp(a) is linked to a higher risk of heart disease, stroke, and other cardiovascular issues, particularly among individuals of African ancestry.

Ten years after learning their polygenic risk score, patients had fewer events—perhaps due to greater use of statin therapy.